239 related articles for article (PubMed ID: 17236563)
1. [Association of molecular biology of lung cancers and their metastasis and prognosis].
Mao YS; Gao YN; He J
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):632-4. PubMed ID: 17236563
[No Abstract] [Full Text] [Related]
2. Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?
Dubinett SM; Elashoff D; Meyerson M
J Clin Oncol; 2004 Aug; 22(16):3209-11. PubMed ID: 15249586
[No Abstract] [Full Text] [Related]
3. Stage IIIB non-small-cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the gene expression in non-small cell lung cancer by cDNA array].
Takada M
Hokkaido Igaku Zasshi; 2004 Jul; 79(4):427-37. PubMed ID: 15373214
[No Abstract] [Full Text] [Related]
5. Prediction of lymph node metastasis using the combined criteria of helical CT and mRNA expression profiling for non-small cell lung cancer.
Chang JW; Yi CA; Son DS; Choi N; Lee J; Kim HK; Choi YS; Lee KS; Kim J
Lung Cancer; 2008 May; 60(2):264-70. PubMed ID: 18280003
[TBL] [Abstract][Full Text] [Related]
6. Refining prognosis in non-small-cell lung cancer.
Larsen JE; Fong KM; Hayward NK
N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225285
[No Abstract] [Full Text] [Related]
7. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
Garland L; Robinson LA; Wagner H
Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
[TBL] [Abstract][Full Text] [Related]
8. Stage II (N1) lung cancer.
Choy O; Jahan T; Roach M; You L; Jablons D
Chest Surg Clin N Am; 2001 Feb; 11(1):39-59, viii. PubMed ID: 11253600
[TBL] [Abstract][Full Text] [Related]
9. [Non-small cell lung cancer].
Yoshimura A; Niitani H
Ryoikibetsu Shokogun Shirizu; 1994; (4):100-3. PubMed ID: 8007089
[No Abstract] [Full Text] [Related]
10. Analysis of paired primary lung and lymph node tumor cells: a model of metastatic potential by multiple genetic programs.
Hoang CD; Guillaume TJ; Engel SC; Tawfic SH; Kratzke RA; Maddaus MA
Cancer Detect Prev; 2005; 29(6):509-17. PubMed ID: 16289389
[TBL] [Abstract][Full Text] [Related]
11. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
[TBL] [Abstract][Full Text] [Related]
12. Treatment of stage I lung cancer.
Walsh GL; Pisters KM; Stevens C
Chest Surg Clin N Am; 2001 Feb; 11(1):17-38, vii. PubMed ID: 11253597
[TBL] [Abstract][Full Text] [Related]
13. [Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
Manegold C; Schirren J; Schneider P; Drings P; Vogt-Moykopf I; Schraube P; Wannenmacher M
Pneumologie; 1996 Oct; 50(10):735-41. PubMed ID: 9019754
[No Abstract] [Full Text] [Related]
14. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
[TBL] [Abstract][Full Text] [Related]
15. [Detection and prognostic significance of micrometastasis in peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation therapy].
Chen TF; Jiang GL; Zhang YQ; Wang LJ; Fu XL; Qian H; Wu KL; Zhao S
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):365-8. PubMed ID: 17892133
[TBL] [Abstract][Full Text] [Related]
16. Stage II (T3) lung cancer.
Allen MS; Jett JR; Kozelsky TF
Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
[TBL] [Abstract][Full Text] [Related]
17. Molecular biologic staging of lung cancer.
D'Amico TA
Ann Thorac Surg; 2008 Feb; 85(2):S737-42. PubMed ID: 18222207
[TBL] [Abstract][Full Text] [Related]
18. The prospect of biologic staging of non-small-cell lung cancer.
Sardari Nia P; Van Marck E; Van Schil P
Clin Lung Cancer; 2005 Jan; 6(4):217-24. PubMed ID: 15694013
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of unresectable stage III non-small-cell lung carcinomas].
Van Houtte P
Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S24-6. PubMed ID: 17404535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
